Replying to @bernardtayet:Beg to differ. Every other week you hear a new trending show people are talking about in the office as well as being shoved into your social media feeds. Whether or not this translates to profitability is another story, but fact is Netflix is constantly in your face.//@bernardtayet:NFLK will fall further as it has not produced a global hit to engage viewers for monetization and to keep up with the few competitors like Disney + among others. @Kiyosumi
DBS's fair value based on promised dividends in 2027 is $72 since they've delivered on their promise up til this year, investors are simply pricing that in. Past that, we're not sure what happens.
Singapore Banks Reach Peak Prices: A Guide for Long-Term Investors
"year-round monthly" , proceeds to illustrate only 10/12 months. Learn, newbies. There's only so much you can trust when reading finance articles. Take in the facts, tune out the noise, and always do your own research.
Constructing a Year-Round Monthly Passive Income Stream Using Singapore Dividend Shares
I'm still holding my D05, not a level to buy right now it's way too overpriced. A bull market is not a good gauge of the time to buy. Selling it at it's current ATH makes more sense.
Watched it go from 6 to now 17. How bullish folks write articles about their favorite stocks never fail to amuse me with the amount of delusion in them even when they have the sense to analyse data and numbers.
$Pfizer(PFE)$ yeah yeah yeah. Wayang to the max. But when it comes to a worldwide pandemic anything goes right? Just push it and make max profit, bribe authorities around the world. Who cares if a few of our customers die, right?
Pfizer Yanks Sickle-Cell Treatment Worldwide After Possible Link to Deaths
I was way too early on $AST SpaceMobile, Inc.(ASTS)$ after researching deeply about them 2 years ago. Had to ride through an immense price drop before the mooning this year. I'm glad they are doing well, nothing but best wishes to them.